Category Archives: Molecular Cardiology

Pune, New York, USA, November 17 2020 (Wiredrelease) Research Dive :The viral spread of coronavirus (COVID-19) is projected to create a considerable impact on the global in-vitro diagnostics market. The reagents & kits segment shall experience huge growth in the global marketplace Continue reading →

November 12, 2020 02:42 ET | Source: Fortune Business Insights Pune, India, Nov. 12, 2020 (GLOBE NEWSWIRE) -- According to the report, the global IVD Market size was valued at USD 61.22 Billion in 2018 is predicted to reach USD 87.11 Billion by 2026, exhibiting a CAGR of 4.5% during the forecast period. North America generated a revenue of USD 23.09 Billion in 2018 and is anticipated to emerge as a dominant region in the global IVD Market during the forecast period. Continue reading →

November 12, 2020 05:58 ET | Source: Research and Markets Dublin, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19 Updates, and Executive and Consultant Guides 2021-2025" report has been added to ResearchAndMarkets.com's offering. Companion Diagnostics are poised to revolutionize the diagnostics industry. Continue reading →

Market Study Report, LLC, has recently added a report on Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology market which offers a comprehensive synopsis of revolving market valuation, market size, SWOT analysis, revenue estimation and geographical spectrum of the market. The report further elucidates primary business obstacles and growth prospects within the forecasted timeline, while examining the current competitive sphere involving key players of the Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology market. The research report on Precision Medicine, Point of Care Devices, Molecular Diagnostics, and Interventional Cardiology market delivers a detailed assessment of this industry landscape, the major trends that define the dynamics over the forecast period are cited, together with regulatory outlook and geographical analysis Continue reading →

YARDLEY, Pa., Nov. 4, 2020 /PRNewswire/ --SOFIE Biosciences, Inc Continue reading →

The second wave of the deadly coronavirus is slowly gripping the United States. Continue reading →

The Europein vitro diagnostics market was valued at $13 billion in 2019, and is expected to reach $18 billion by 2027, registering a CAGR of 4.8% from 2019 to 2027. Continue reading →

YARDLEY, Pa., Nov. 4, 2020 /PRNewswire/ --SOFIE Biosciences, Inc. ("SOFIE"), an established radiopharmaceutical supplier and worldwide radiopharmaceutical contract manufacturing organization, and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, announced that both the organizations have entered into a strategic partnership. Continue reading →

A three-day international webinar on Advances in cancer biology and therapeutics will be organised by the Biochemistry and Bioinformatics Department of GITAM Deemed to be University from November 5 to 7. Convener Malla Rama Rao informed on Tuesday that top scientists from India, the USA, the UK and researchers will participate in the webinar to deliver the lectures on various related topics. Continue reading →

Nov. 4, 2020 12:30 UTC PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc.(NASDAQ: ARWR) today announced that on November 18, and November 19, 2020, it will host two key opinion leader (KOL) webinars to discuss the companys two investigational RNA interference (RNAi) based cardiometabolic candidates, ARO-APOC3 and ARO-ANG3 Continue reading →